151 related articles for article (PubMed ID: 1680223)
1. The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.
Przegaliński E; Jaworska L; Konarska R; Gołembiowska K
Neuropeptides; 1991 Jul; 19(3):189-95. PubMed ID: 1680223
[TBL] [Abstract][Full Text] [Related]
2. The role of dopamine receptors in the release of thyrotropin-releasing hormone from the rat striatum and nucleus accumbens: an in vitro study.
Przegaliński E; Jaworska L; Budziszewska B
Neuropeptides; 1993 Nov; 25(5):277-82. PubMed ID: 7906871
[TBL] [Abstract][Full Text] [Related]
3. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
4. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
[TBL] [Abstract][Full Text] [Related]
5. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
Hu XT; Wachtel SR; Galloway MP; White FJ
J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
[TBL] [Abstract][Full Text] [Related]
6. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
Zetterström T; Sharp T; Ungerstedt U
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
[TBL] [Abstract][Full Text] [Related]
7. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
8. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
Consolo S; Wu CF; Fusi R
J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
[TBL] [Abstract][Full Text] [Related]
9. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA.
Boldry RC; Willins DL; Wallace LJ; Uretsky NJ
Brain Res; 1991 Sep; 559(1):100-8. PubMed ID: 1685936
[TBL] [Abstract][Full Text] [Related]
10. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
Barnes JM; Barnes NM; Costall B; Naylor RJ
Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
[TBL] [Abstract][Full Text] [Related]
11. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
12. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
Clark D; Salah RS; Galloway MP
Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
Wedzony K; Limberger N; Späth L; Wichmann T; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):250-5. PubMed ID: 3264055
[TBL] [Abstract][Full Text] [Related]
14. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
15. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
Zarrindast MR; Amin R
Psychopharmacology (Berl); 1992; 106(1):67-70. PubMed ID: 1346722
[TBL] [Abstract][Full Text] [Related]
16. Noradrenaline but not dopamine involved in NMDA receptor-mediated hyperalgesia induced by theophylline in awake rats.
Paalzow GH
Eur J Pharmacol; 1994 Jan; 252(1):87-97. PubMed ID: 7908645
[TBL] [Abstract][Full Text] [Related]
17. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
LaHoste GJ; Marshall JF
Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501
[TBL] [Abstract][Full Text] [Related]
18. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
Serra G; Collu M; Gessa GL
Psychopharmacology (Berl); 1987; 91(3):330-3. PubMed ID: 2882540
[TBL] [Abstract][Full Text] [Related]
19. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
Yoshikawa T; Fukamauchi F; Shibuya H; Takahashi R
Neuropeptides; 1989; 13(2):103-5. PubMed ID: 2567971
[TBL] [Abstract][Full Text] [Related]
20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
